Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe

A.C.G. Egberts, N.S. Vermeer, R.G. Duijnhoven, S.M.J.M. Strauss, A.K. Mantel-Teeuwisse, P.R. Arlett, H.G.M. Leufkens, M.L.H. de Bruijn

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)723-731
Number of pages9
JournalClinical Pharmacology & Therapeutics
Volume96
Publication statusPublished - 2014

Cite this